TIL (Instil Bio Inc.) stock: $7.17, $48.6M market cap, $5.5M cash, $43.1M EV, $48.8M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Share price
$7.17
Market cap
$48.6M
Cash
$5.5M
Enterprise value
$43.1M
Balance sheet
Cash
$5.5M
Debt
$0.0M
Net cash
$5.5M
Enterprise value
$43.1M
Basic shares
6.8M shares
Fully diluted shares
6.8M shares
Fully diluted market cap
$48.8M
Cash per share
$0.81
Cash figures as of 2026-06-30. Database snapshot: 2026-09-22.
Price history
Loading TIL daily closes…
Loading price history…
Pipeline assets
AXN-2510
Phase 1 · TerminatedModality: bispecific antibody
Target PD-L1 / VEGF family
Indications
Relapsed/refractory solid tumors(Phase 1)
Status note Former lead product candidate. IND cleared in June 2025 for a Phase 1 trial in relapsed/refractory solid tumors; development discontinued in January 2026 and all rights transferred back to ImmuneOnco.
AXN-27M
Stage not disclosed · TerminatedModality: bispecific antibody
Status note Development discontinued in January 2026 alongside AXN-2510; all rights transferred back to ImmuneOnco. The company states it currently has no product candidate in active development.
Per-asset detail extracted from the 10-Q filed 2026-08-13. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.